Evidence map›Paper›PMID 40251220›Full record

ArticleScientific reports2025

Feasibility of virtual reality to induce and measure optokinetic after-nystagmus (OKAN): a pilot study.

Marie Reynders, Jelte Bos, Agali Mert, Jaouad Abari, Ina Foulon

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marie ReyndersDepartment of Otorhinolaryngology and Head & Neck Surgery, University Hospital of Brussels, Brussels, Belgium. marie.reynders@uzbrussel.be.
Jelte BosFaculty of Behavioural and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Agali MertMert Medical, Houten, The Netherlands.
Jaouad AbariDepartment of Otorhinolaryngology and Head & Neck Surgery, University Hospital of Brussels, Brussels, Belgium.
Ina FoulonDepartment of Otorhinolaryngology and Head & Neck Surgery, University Hospital of Brussels, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optokinetic nystagmus (OKN) is a reflexive eye movement triggered by repetitive motion in the visual field, characterized by a slow phase tracking the motion and a fast phase resetting the eye position. Following OKN, optokinetic after-nystagmus (OKAN) occurs in darkness, decaying over time and reflecting vestibular function. While OKAN provides valuable insights into vestibular disorders such as uni- or bilateral vestibulopathy and persistent postural perceptual dizziness (PPPD), traditional assessments require large and complex setups, limiting clinical application. This pilot study explores the feasibility of using a commercially available virtual reality (VR) headset with integrated eye-tracking to induce and measure OKAN. Twenty-two healthy participants (median age: 42 years, 54% female) with normal audiological and vestibular function were exposed to 60s of horizontal optokinetic stimulation. OKN was observed in 13 participants, with OKAN detected in 69% of these cases, consistent with traditional methods (55-90%). The median time constant (TC) of 18.75 ± 6.84s also aligns well with values reported for traditional methods (13.95-23.4s). This pilot study demonstrates that VR-based OKAN measurement is feasible and comparable to traditional methods, offering a promising tool for clinical applications in diagnosing vestibular disorders.

Indexed as

Nystagmus, OptokineticVirtual RealityAdultEye MovementsFeasibility StudiesFemaleHumansMaleMiddle AgedPilot ProjectsVestibular DiseasesYoung Adult

Identifiers

PMID40251220
PMCPMC12008418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.